Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes

  • Corzana, Francisco
  • Asín, Alicia
  • Eguskiza, Ander
  • De Tomi, Elisa
  • Martín-Carnicero, Alfonso
  • Martínez-Moral, María P.
  • Mangini, Vincenzo
  • Papi, Francesco
  • Bretón, Carmen
  • Oroz, Paula
  • Lagartera, Laura
  • Jiménez-Moreno, Ester
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Nativi, Cristina
  • Asensio, Juan Luis
  • Hurtado-Guerrero, Ramón
  • Peregrina, Jesús M.
  • Malerba, Giovanni
  • Martínez, Alfredo
  • Fiammengo, Roberto
Pancreatic cancer is one of the deadliest cancers worldwide, mainly due to late diagnosis. Therefore, there is an urgent need for novel diagnostic approaches to identify the disease as early as possible. We have developed a diagnostic assay for pancreatic cancer based on the detection of naturally occurring tumor associated autoantibodies against Mucin-1 (MUC1) using engineered glycopeptides on nanoparticle probes. We used a structure-guided approach to develop unnatural glycopeptides as model antigens for tumor-associated MUC1. We designed a collection of 13 glycopeptides to bind either SM3 or 5E5, two monoclonal antibodies with distinct epitopes known to recognize tumor associated MUC1. Glycopeptide binding to SM3 or 5E5 was confirmed by surface plasmon resonance and rationalized by molecular dynamics simulations. These model antigens were conjugated to gold nanoparticles and used in a dot-blot assay to detect autoantibodies in serum samples from pancreatic cancer patients and healthy volunteers. Nanoparticle probes with glycopeptides displaying the SM3 epitope did not have diagnostic potential. Instead, nanoparticle probes displaying glycopeptides with high affinity for 5E5 could discriminate between cancer patients and healthy controls. Remarkably, the best-discriminating probes show significantly better true and false positive rates than the current clinical biomarkers CA19-9 and carcinoembryonic antigen (CEA)., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No956544. We thank Dr. Sara Gasperini of the General Pathology Section, Department of Medicine, University of Verona, for providing access and assistance with the LI–COR Odyssey Infrared Imaging System. We thank Prof.Henrik Clausen from Copenhagen Center for Glycomics atUniversity of Copenhagen for his insightful comments. F.C.thanks the Mizutani Foundation for Glycoscience (grant220115) and AECC (INNOVA 2023 project). A.A. and C.B.thank the Asociación Española Contra el Cáncer (AECC),sección La Rioja, for their doctoral fellow ships. We thank the ALBA (Barcelona, Spain) synchrotron beamline XA-LOC. We thank ARAID, the Agencia Estatal de Investiga-ción (AEI, BFU201675633-P, PID2019-105451GB-I00, and PID2022-136362NB-I00 to R.H.-G., PID2022-136735OB-I00to A.M., PID2021-127030OA-I00 to E.J.-M, PID2022-141085NB-100 to J.L.A, and PID2021-127622OB-I00 andPDC2022-133725-C21 to F.C. and J.H.B.), Universidad de La Rioja (REGI22/47 and REGI22/16), Gobierno de Aragón (E34_R17 and LMP58_18 to R.H.-G.) with FEDER(2014–2020) funds for “Building Europe from Aragón” forfinancial support, and the COST Action CA18103 INNO-GLY: Innovation with Glycans new frontiers from synthesis to new biological targets. CN thanks Fondazione AIRC,project IG25762. Open Access publishing facilitated byUniversità degli Studi di Verona, as part of the Wiley -CRUI-CARE agreement., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Rational design of dual-domain binding inhibitors for N-acetylgalactosamine transferase 2 with improved selectivity over the T1 and T3 isoforms

  • Compañón, Ismael
  • Ballard, Collin J.
  • Lira-Navarrete, Erandi
  • Santos, Tanausú
  • Monaco, Serena
  • Muñoz-García, Juan C.
  • Delso, J. Ignacio
  • Angulo, Jesús
  • Gerken, Thomas A.
  • Schjoldager, Katrine T.
  • Clausen, Henrik
  • Tejero, Tomás
  • Merino, Pedro
  • Corzana, Francisco
  • Hurtado-Guerrero, Ramón
  • Ghirardello, Mattia
The GalNAc-transferase (GalNAc-T) family, consisting of 20 isoenzymes, regulates the O-glycosylation process of mucin glycopeptides by transferring GalNAc units to serine/threonine residues. Dysregulation of specific GalNAc-Ts is associated with various diseases, making these enzymes attractive targets for drug development. The development of inhibitors is key to understanding the implications of GalNAc-Ts in human diseases. However, developing selective inhibitors for individual GalNAc-Ts represents a major challenge due to shared structural similarities among the isoenzymes and some degree of redundancy among the natural substrates. Herein, we report the development of a GalNAc-T2 inhibitor with higher potency compared to those of the T1 and T3 isoforms. The most promising candidate features bivalent GalNAc and thiophene moieties on a peptide chain, enabling binding to both the lectin and catalytic domains of the enzyme. The binding mode was confirmed by competitive saturation transfer difference NMR experiments and validated through molecular dynamics simulations. The inhibitor demonstrated an IC50 of 21.4 μM for GalNAc-T2, with 8- and 32-fold higher selectivity over the T3 and T1 isoforms, respectively, representing a significant step forward in the synthesis of specific GalNAc-T inhibitors tailored to the unique structural features of the targeted isoform., We thank the Agencia Estatal de Investigación (AEI, PID2021-127622OB-I00 and PDC2022-133725-C21 to F.C., PID2022-136362NB-I00 to R.H.-G., PID2022137973NB-I00 to P.M.), Universidad de La Rioja (REGI22/16 Project), and Gobierno de Aragón (E34_R17 and LMP58_18) with FEDER (2014–2020) funds for ‘Building Europe from Aragón’ for financial support (to R.H.-G.). The support of the National Institutes of Health grant R01-GM113535 (to T.A.G.) is also acknowledged. M.G. and I.D. acknowledge the Marie Skłodowska-Curie fellowship program (grant agreement nos. 101034288 (M.G.) and 890779 (I.D.)) for financial support. J.A. and S.M. acknowledge support of BBSRC, grant BB/P010660/1. J.A. and J.C.M.-G. also acknowledge funding from the grant AEI/10.13039/501100011033/PID2022-142879NB-I00, cofunded by the European Regional Development Fund (ERDF), “A way of making Europe”, and T.S. thanks MICIU/AEI /10.13039/501100011033 and the European Union NextGenerationEU/PRTR for his Juan de la Cierva contract, JDC2022-048607-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

STD NMR Epitope Perturbation by Mutation Unveils the Mechanism of YM155 as an Arginine-Glycosyltransferases Inhibitor Effective in Treating Enteropathogenic Diseases

  • Ramírez-Cárdenas, Jonathan
  • Taleb, Víctor
  • Calvaresi, Valeria
  • Struwe, Weston B
  • El Qaidi, Samir
  • Zhu, Congrui
  • Hasan, Kamrul
  • Zhang, Yingxin
  • Hardwidge, Philip R.
  • Veloz, Billy
  • Muñoz-García, Juan C.
  • Hurtado-Guerrero, Ramón
  • Angulo, Jesús
Enteropathogenic arginine-glycosyltransferases (Arg-GTs) alter higher eukaryotic proteins by attaching a GlcNAc residue to arginine acceptor sites, disrupting essential pathways such as NF-κB signaling, which promotes bacterial survival. These enzymes are potential drug targets for treating related diseases. In this study, we present a novel STD NMR Epitope Perturbation by Mutation spectroscopic approach that, in combination with hydrogen-deuterium exchange mass spectrometry (HDX-MS), and molecular dynamics simulations, shows that the highly potent broad-spectrum anticancer drug YM155 serves as a potential noncompetitive inhibitor of these enzymes. It induces a conformation of the arginine acceptor site unfavorable for GlcNAc transfer, which underlies the molecular mechanism by which this compound exerts its inhibitory function. Finally, we also demonstrate that YM155 effectively treats enteropathogenic diseases in a mouse model, highlighting its therapeutic potential. Overall, our data suggest that this compound can be repurposed to not only treat cancer but also infectious diseases., This research was funded by the Ministerio de Ciencia, Innovación y Universidades MICIU/AEI/10.13039/501100011033 and by the European Regional Development Fund, ERDF, EU, via the grants PID2022-142879NB-I00 to J.A. and PID2022-136362NB-100 to R.H.-G. and the Gobierno de Aragón (E34_R17 and LMP58_18) with ERDF (2014–2020) funds for ‘Building Europe from Aragón’ for financial support (to R.H.-G.). W.B.S. and V.C. acknowledge funding from the UKRI Future Leaders Fellowship MR/V02213X/1., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure, function, and implications of fucosyltransferases in health and disease

  • Ghirardello, Mattia
  • Yruela Guerrero, Inmaculada
  • Merino, Pedro
  • Sackstein, Robert
  • Sanz-Martínez, Ignacio
  • Hurtado-Guerrero, Ramón
Fucosylation is a ubiquitous glycosylation event that shapes cellular communication and immunity. Catalyzed by fucosyltransferases (FUTs), this reaction encompasses diverse substrates, mechanisms, and biologic consequences. In this Review, we explore the structural and functional landscape of FUTs primarily from higher eukaryotes, with focus on the mechanistic determinants of regioselectivity, donor/acceptor coordination, and domain modularity. We highlight advances in structural biology, modeling, and enzyme engineering that clarify how FUTs decode glycan topology and specificity. Phylogenetic and structural analyses reveal two major clades of human FUTs that differ in GDP-Fuc recognition and conformational flexibility, providing a molecular rationale for their mechanistic divergence. Drawing from mammalian FUT studies, we propose a conceptual framework in which distinct family members exploit strategies including donor-induced conformational changes, exosite interactions, or local peptide cues to achieve specificity and catalytic efficiency. We also examine their roles in physiology, inflammation, immune regulation, and cancer, and summarize current FUT inhibitors and enzyme-based therapeutic strategies., We thank the Spanish MICINN (grants PID2022-137973NB-I00 to P.M. and PID2022-136362NB-I00 to R.H.-G., and predoctoral FPI fellowship to I.S.-M.) and the Gobierno de Aragón (grant E34_20R) with FEDER (2014–2020) funds for “Building Europe from Aragón” for financial support. M.G. acknowledges the Scientific Foundation of the Spanish Association Against Cancer (INVES246008GHIR) for supporting this work. I.Y. acknowledges funding from the Government of Aragón-FEDER (grant E35_23R) for “Building Europe from Aragón”. R.H.-G. acknowledges support of the European Union’s Horizon Europe research and innovation program under the Marie Skłodowska-Curie Actions Grant (Agreement n. 101119601, “GLYCANDRUG”). R.S. acknowledges support from the United States National Institutes of Health/National Cancer Institute grant NCI U01 CA225730 (“Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis”)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

FUT8 catalysis involves GDP-fucose–induced loop activation promoting a reaction at the SN1-SN2 frontier

  • Sanz-Martínez, Ignacio
  • Tejero, Tomás
  • Hurtado-Guerrero, Ramón
  • Merino, Pedro
α1,6-Fucosyltransferase 8 (FUT8) catalyzes the core α1,6-fucosylation of N-glycans, a modification essential for the biological function of many mammalian glycoproteins. Despite its importance, the structural and mechanistic aspects of FUT8 catalysis remain incompletely understood. Here, we combine molecular dynamics, QM/MM, and metadynamics simulations to delineate the full catalytic cycle of FUT8. We reveal that GDP-fucose binding induces a concerted conformational rearrangement of two flexible loops, which cooperatively stabilize a closed, catalytically competent active site. Formation of the Michaelis complex primes the enzyme for fucose transfer via a slightly late and highly asynchronous SN2 inverting mechanism. In fact, the reaction proceeds through a late transition state in a single kinetic step (energy barrier ∼18 kcal/mol, consistent with experimental kcat values) but in three different stages, i.e.: (i) cleavage of the glycosidic bond between fucose and GDP, (ii) formation of the glycosidic bond and (iii) H-transfer from the acceptor to the catalytic Glu373, underscoring the asynchronous nature of this process. Moreover, topological calculations of the electron localization function (ELF) along the reaction coordinate reveal the transient formation of an intimate ion pair, with a lifetime of 350–800 fs, as a transient intermediate; notably, despite the cationic character of the transition state, no stable intermediate is formed. These findings highlight how structural rearrangements enable a chemically distinct catalytic process and provide a structural framework for rational inhibitor design., We thank the Spanish MICINN (grants PID2022-137973NB-I00 to P.M. and PID2022-136362NB-I00 to R.H.-G., and predoctoral FPI fellowship to I.S.-M.) and Gobierno de Aragón (E34_20R) with FEDER (2014–2020) funds for “Building Europe from Aragón”for financial support. Resources from the supercomputers “Agustina″ (provided by BIFI-ZCAM, University of Zaragoza, Spain) and “Castor&Polux” (provided by the Biological and Computational Chemistry Group) are gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis of Polyhydroxylated Pyrrolidinyl Analogs of Sugar Nucleotides. Experimental and Computational Studies on Their Interactions With GalNAC-T's

  • Merino, Pedro
  • Juste, Veronica
  • Montesa, Alejandro
  • Pereira, Sandra
  • Orta, Sara
  • Pedrón, Manuel
  • Jiménez, Ana I.
  • Martín-Santamaría, Sonsoles
  • Hurtado-Guerrero, Ramón
  • Delso, Ignacio
  • Tejero, Tomás
Direct coupling between polyhydroxylated pyrrolidinyl β-amino phosphonates and uridine monophosphate (UMP) yields polyhydroxylated pyrrolidinyl analogs of sugar nucleotides suitable inhibitors of N-acetyl-galactosyltransferases. β-Amino phosphonates have been synthesized in an enantiomerically pure form through the nucleophilic addition of a phosphonate to polyhydroxylated cyclic nitrones. The reaction has been studied in detail and excellent diastereoselectivities are obtained in agreement with a stereochemical model well supported by density functional theory calculations. Binding of the nucleotide analogs with N-acetylgalactosyltransferases GalNAc-T2, GalNAc-T14, and GalNAc-T16 has been studied both experimentally and computationally through molecular dynamics simulations. Saturation transfer difference nuclear magnetic resonance experiments and measurement of Kd values have been used to validate the binding model at the active site. These studies provide important information of the role of the pyrophosphate and pyrrolidinyl moieties on the observed affinity, We thank Ministerio de Ciencia e Innovacion (MICINN, Spain) (Projects PID2022-137973NB-I00 and PID2019-104090RB-I00 to P.M.; PID2022 136362NB-I00 to R.H.-G. and PID2020-113588RB-I00 and PID2023 152271NB-I00 to S.M.-S.) and Government of Aragón (Spain) (Grupos Consolidados, E34_20R) for financial support. V.J. and S.P. thank also MICINN for FPI predoctoral contracts. A.M., M.P., and S.O. thank Government of Aragon for predoctoral contracts., Peer reviewed, Sin experimentacion animal ni uso de NAMs
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase

  • Piniello, Beatriz
  • Macías-León, Javier
  • Miyazaki, Shun
  • García-García, Ana
  • Compañón, Ismael
  • Ghirardello, Mattia
  • Taleb, Víctor
  • Veloz, Billy
  • Corzana, Francisco
  • Miyagawa, Atsushi
  • Rovira, Carme
  • Hurtado-Guerrero, Ramon
Soluble HMW1C-like N-glycosyltransferases (NGTs) catalyze the glycosylation of Asn residues in proteins, a process fundamental for bacterial autoaggregation, adhesion and pathogenicity. However, our understanding of their molecular mechanisms is hindered by the lack of structures of enzymatic complexes. Here, we report structures of binary and ternary NGT complexes of Aggregatibacter aphrophilus NGT (AaNGT), revealing an essential dyad of basic/acidic residues located in the N-terminal all α-domain (AAD) that intimately recognizes the Thr residue within the conserved motif Asn0-X+1-Ser/Thr+2. Poor substrates and inhibitors such as UDP-galactose and UDP-glucose mimetics adopt non-productive conformations, decreasing or impeding catalysis. QM/MM simulations rationalize these results, showing that AaNGT follows a SN2 reaction mechanism in which the acceptor asparagine uses its imidic form for catalysis and the UDP-glucose phosphate group acts as a general base. These findings provide key insights into the mechanism of NGTs and will facilitate the design of structure-based inhibitors to treat diseases caused by non-typeable H. influenzae or other Gram-negative bacteria.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Otros (Other)

Systematic strategy for the development of glycosyltransferase inhibitors: diversity-oriented synthesis of FUT8 inhibitors

  • Manabe, Yoshiyuki
  • Fukase, Koichi
  • Hizume, Koki
  • Takakura, Yohei
  • Takamatsu, Shinji
  • Miyoshi, Eiji
  • Kamada, Yoshihiro
  • Hurtado-Guerrero, Ramón
Glycans control various biological processes, depending on their structures. Particularly, core fucose, formed by α1,6-fucosyltransferase (FUT8), has a substantial influence on multiple biological processes. In this study, we investigated the development of FUT8 inhibitors with structural elements encompassing both the glycosyl donor (GDP-fucose) and acceptor (N-glycan) of FUT8. To efficiently optimize the structure of FUT8 inhibitors, we employed a strategy involving fragmentation of the target structure, followed by a structure optimization using a diversity-oriented synthesis approach. This study proposes an efficient strategy to accelerate the structural optimization of middle molecules.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Contribución de congreso (ConferenceOutput)

Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2

  • Manabe, Yoshiyuki
  • Gárate-Reyes, Brandon
  • Ito, Keita
  • Hurtado-Guerrero, Ramón
  • Kabayama, Kazuya
  • Fukase, Koichi
We synthesized and evaluated Pam3CSK4-conjugated receptor binding domain (RBD)/deglycosylated RBD as potential anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates. Our investigation revealed the critical importance of limiting the number of introduced Pam3CSK4 molecules to the RBD in order to preserve its antigenicity. We also confirmed the harmonious integration of the adjuvant-conjugation strategy with the glycan-shield removal strategy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality

  • Albert, Marie-Christine
  • Uranga-Murillo, Iratxe
  • Arias, Maykel
  • De Miguel, Diego
  • Peña, Natacha
  • Montinaro, Antonella
  • Varanda, Ana Beatriz
  • Theobald, Sebastian J.
  • Areso, Itziar
  • Saggau, Julia
  • Koch, Manuel
  • Liccardi, Gianmaria
  • Peltzer, Nieves
  • Rybniker, Jan
  • Hurtado-Guerrero, Ramón
  • Merino, Pedro
  • Monzón, Marta
  • Badiola, Juan J.
  • Reindl-Schwaighofer, Roman
  • Sanz-Pamplona, Rebeca
  • Cebollada-Solanas, Alberto
  • Megyesfalvi, Zsolt
  • Dome, Balazs
  • Secrier, Maria
  • Hartmann, Boris
  • Bergmann, Michael
  • Pardo, Julián
  • Walczak, Henning
The dysregulated immune response and inflammation resulting in severe COVID-19 are still incompletely understood. Having recently determined that aberrant death-ligand-induced cell death can cause lethal inflammation, we hypothesized that this process might also cause or contribute to inflammatory disease and lung failure following SARS-CoV-2 infection. To test this hypothesis, we developed a novel mouse-adapted SARS-CoV-2 model (MA20) that recapitulates key pathological features of COVID-19. Concomitantly with occurrence of cell death and inflammation, FasL expression was significantly increased on inflammatory monocytic macrophages and NK cells in the lungs of MA20-infected mice. Importantly, therapeutic FasL inhibition markedly increased survival of both, young and old MA20-infected mice coincident with substantially reduced cell death and inflammation in their lungs. Intriguingly, FasL was also increased in the bronchoalveolar lavage fluid of critically-ill COVID-19 patients. Together, these results identify FasL as a crucial host factor driving the immuno-pathology that underlies COVID-19 severity and lethality, and imply that patients with severe COVID-19 may significantly benefit from therapeutic inhibition of FasL.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Detection of tumor-associated autoantibodies in the sera of pancreatic cancer patients using engineered muc1 glycopeptide nanoparticle probes

  • Corzana, Francisco
  • Asín, Alicia
  • Eguskiza, Ander
  • De Tomi, Elisa
  • Martín-Carnicero, Alfonso
  • Martínez-Moral, María P.
  • Mangini, Vincenzo
  • Papi, Francesco
  • Bretón, Carmen
  • Oroz, Paula
  • Lagartera, Laura
  • Jiménez-Moreno, Ester
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Nativi, Cristina
  • Asensio, Juan L.
  • Hurtado-Guerrero, Ramón
  • Peregrina, Jesús M.
  • Malerba, Giovanni
  • Martínez, Alfredo
  • Fiammengo, Roberto
Pancreatic cancer is one of the deadliest cancers worldwide, mainly due to late diagnosis. Therefore, there is an urgent need for novel diagnostic approaches to identify the disease as early as possible. We have developed a diagnostic assay for pancreatic cancer based on the detection of naturally occurring tumor associated autoantibodies against Mucin‐1 (MUC1) using engineered glycopeptides on nanoparticle probes. We used a structure‐guided approach to develop unnatural glycopeptides as model antigens for tumor‐associated MUC1. We designed a collection of 13 glycopeptides to bind either SM3 or 5E5, two monoclonal antibodies with distinct epitopes known to recognize tumor associated MUC1. Glycopeptide binding to SM3 or 5E5 was confirmed by surface plasmon resonance and rationalized by molecular dynamics simulations. These model antigens were conjugated to gold nanoparticles and used in a dot‐blot assay to detect autoantibodies in serum samples from pancreatic cancer patients and healthy volunteers. Nanoparticle probes with glycopeptides displaying the SM3 epitope did not have diagnostic potential. Instead, nanoparticle probes displaying glycopeptides with high affinity for 5E5 could discriminate between cancer patients and healthy controls. Remarkably, the best‐discriminating probes show significantly better true and false positive rates than the current clinical biomarkers CA19‐9 and carcinoembryonic antigen (CEA).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Rational Design of Dual-Domain Binding Inhibitors for N-Acetylgalactosamine Transferase 2 with Improved Selectivity over the T1 and T3 Isoforms

  • Compañón, Ismael
  • Ballard, Collin J.
  • Lira-Navarrete, Erandi
  • Santos, Tanausú
  • Monaco, Serena
  • Muñoz-García, Juan C.
  • Delso, Ignacio
  • Angulo, Jesus
  • Gerken, Thomas A.
  • Schjoldager, Katrine T.
  • Clausen, Henrik
  • Tejero, Tomás
  • Merino, Pedro
  • Corzana, Francisco
  • Hurtado-Guerrero, Ramon
  • Ghirardello, Mattia
The GalNAc-transferase (GalNAc-T) family, consisting of 20 isoenzymes, regulates the O-glycosylation process of mucin glycopeptides by transferring GalNAc units to serine/threonine residues. Dysregulation of specific GalNAc-Ts is associated with various diseases, making these enzymes attractive targets for drug development. The development of inhibitors is key to understanding the implications of GalNAc-Ts in human diseases. However, developing selective inhibitors for individual GalNAc-Ts represents a major challenge due to shared structural similarities among the isoenzymes and some degree of redundancy among the natural substrates. Herein, we report the development of a GalNAc-T2 inhibitor with higher potency compared to those of the T1 and T3 isoforms. The most promising candidate features bivalent GalNAc and thiophene moieties on a peptide chain, enabling binding to both the lectin and catalytic domains of the enzyme. The binding mode was confirmed by competitive saturation transfer difference NMR experiments and validated through molecular dynamics simulations. The inhibitor demonstrated an IC50 of 21.4 μM for GalNAc-T2, with 8- and 32-fold higher selectivity over the T3 and T1 isoforms, respectively, representing a significant step forward in the synthesis of specific GalNAc-T inhibitors tailored to the unique structural features of the targeted isoform.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Development of a FUT8 Inhibitor with Cellular Inhibitory Properties

  • Manabe, Yoshiyuki
  • Takebe, Tomoyuki
  • Kasahara, Satomi
  • Hizume, Koki
  • Kabayama, Kazuya
  • Kamada, Yoshihiro
  • Asakura, Akiko
  • Shinzaki, Shinichiro
  • Takamatsu, Shinji
  • Miyoshi, Eiji
  • García-García, Ana
  • Vakhrushev, Sergey Y.
  • Hurtado-Guerrero, Ramón
  • Fukase, Koichi
Core fucosylation is catalyzed by α‐1,6‐fucosyltransferase (FUT8), which fucosylates the innermost GlcNAc of N‐glycans. Given the association of FUT8 with various diseases, including cancer, selective FUT8 inhibitors applicable to in vivo or cell‐based systems are highly sought‐after. Herein, we report the discovery of a compound that selectively inhibits FUT8 in cell‐based assays. High‐throughput screening revealed a FUT8‐inhibiting pharmacophore, and further structural optimization yielded an inhibitor with a KD value of 49 nM. Notably, this binding occurs only in the presence of GDP (a product of the enzymatic reaction catalyzed by FUT8). Mechanistic studies suggested that this inhibitor generates a highly reactive naphthoquinone methide derivative at the binding site in FUT8, which subsequently reacts with FUT8. Furthermore, prodrug derivatization of this inhibitor improved its stability, enabling suppression of core fucose expression and subsequent EGFR and T‐cell signaling in cell‐based assays, paving the way for the development of drugs targeting core fucosylation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Loop engineering of enzymes to control their immobilization and ultimately fabricate more efficient heterogeneous biocatalysts

  • Zeballos, Nicoll
  • Ginés-Alcober, Irene
  • Macías-León, Javier
  • Andrés-Sanz, Daniel
  • González-Ramírez, Andrés Manuel
  • Sánchez-Costa, Mercedes
  • Merino, Pedro
  • Hurtado-Guerrero, Ramón
  • López-Gallego, Fernando
Enzyme immobilization is indispensable for enhancing enzyme performance in various industrial applications. Typically, enzymes require specific spatial arrangements for optimal functionality, underscoring the importance of correct orientation. Despite well‐known N‐ or C‐terminus tailoring techniques, alternatives for achieving orientation control are limited. Here, we propose a novel approach that tailors the enzyme surface with engineered His‐rich loops. To that aim, we first solve the X‐ray crystal structure of a hexameric alcohol dehydrogenase from Thermus thermophilus HB27 (TtHBDH) (PDB: 9FBD). Guided by this 3D structure, we engineer the enzyme surface with a new loop enriched with six His residues to control enzyme orientation. Molecular dynamics simulations reveal that the engineered loop's imidazole rings have greater solvent accessibility than those in native His residues, allowing for more efficient enzyme immobilization on certain metal chelate‐functionalized carriers. Using carriers functionalized with iron (III)‐catechol, the apparent Vmax of the immobilized loop variant doubles the immobilized His‐tagged one, and vice versa when both variants are immobilized on carriers functionalized with copper (II)‐imidodiacetic acid. His‐tagged and loop‐engineered TtHBDH show high operational stability reaching 100% bioconversion after 10 reaction cycles, yet the loop variant is faster than the His‐tagged one.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

STD NMR Epitope Perturbation by Mutation Unveils the Mechanism of YM155 as an Arginine-Glycosyltransferases Inhibitor Effective in Treating Enteropathogenic Diseases

  • Ramírez-Cárdenas, Jonathan
  • Taleb, Víctor
  • Calvaresi, Valeria
  • Struwe, Weston B.
  • El Qaidi, Samir
  • Zhu, Congrui
  • Hasan, Kamrul
  • Zhang, Yingxin
  • Hardwidge, Philip R.
  • Veloz, Billy
  • Muñoz-García, Juan C.
  • Hurtado-Guerrero, Ramón
  • Angulo, Jesús
Enteropathogenic arginine-glycosyltransferases (Arg-GTs) alter higher eukaryotic proteins by attaching a GlcNAc residue to arginine acceptor sites, disrupting essential pathways such as NF-κB signaling, which promotes bacterial survival. These enzymes are potential drug targets for treating related diseases. In this study, we present a novel STD NMR Epitope Perturbation by Mutation spectroscopic approach that, in combination with hydrogen–deuterium exchange mass spectrometry (HDX-MS), and molecular dynamics simulations, shows that the highly potent broad-spectrum anticancer drug YM155 serves as a potential noncompetitive inhibitor of these enzymes. It induces a conformation of the arginine acceptor site unfavorable for GlcNAc transfer, which underlies the molecular mechanism by which this compound exerts its inhibitory function. Finally, we also demonstrate that YM155 effectively treats enteropathogenic diseases in a mouse model, highlighting its therapeutic potential. Overall, our data suggest that this compound can be repurposed to not only treat cancer but also infectious diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Structure-guided phage display discovery of antibodies for (S)Tn-glycans in protein context

  • Hurtado-Guerrero, Ramón
  • Spyridon, Gatos
  • Ginés-Alcober, Irene
  • Macías-León, Javier
  • González-Ramírez, Andrés Manuel
  • Kasapoglu, Ilknur
  • Veloz, Billy
  • Compañón, Ismael
  • Ghirardello, Mattia
  • Merino, Pedro
  • Corzana, Francisco
  • Blixt, Ola
Developing high-affinity monoclonal antibodies (mAbs) against tumor-associated carbohydrate antigens such as Tn and STn on carrier proteins remains a major challenge in cancer therapy. These antigens, expressed as glycan–peptide epitopes (combotopes), require precise recognition for high specificity. Through structural studies, we found that VH domains of certain antibodies primarily recognize glycans, whereas VL domains bind peptide sequences. Using these insights, we developed a VH-focused and VL-diverse phage display library to discover mAbs with combotope-binding characteristics. Notably, structural analysis enabled us to convert Tn-specific mAbs into STn-specific mAbs through modification of VH complementarity-determining region 3, demonstrating the versatility of this approach. Our hypothesis was validated with glycoprotein targets MUC1 and CD43, yielding antibodies with high specificity and affinity. Furthermore, internalization studies using the parental antibody scaffold show efficient uptake by tumor cells, supporting its use in antibody–drug conjugates. This platform addresses the challenge of generating glycoform-specific antibodies for cancer therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Microbial binding module employs sophisticated clustered saccharide patches to selectively adhere to mucins

  • Jaroentomeechai, Thapakorn
  • Veloz, Billy
  • Soares, Cátia O.
  • Goerdeler, Felix
  • Grosso, Ana Sofia
  • Büll, Christian
  • Miller, Rebecca L.
  • Furukawa, Sanae
  • Ginés-Alcober, Irene
  • Taleb, Víctor
  • Merino, Pedro
  • Ghirardello, Mattia
  • Compañón, Ismael
  • Coelho, Helena
  • Dias, Jorge S.
  • Vincentelli, Renaud
  • Henrissat, Bernard
  • Joshi, Hiren
  • Clausen, Henrik
  • Corzana, Francisco
  • Marcelo, Filipa
  • Hurtado-Guerrero, Ramon
  • Narimatsu, Yoshiki
The mucus lining wet body surfaces forms the interphase and barrier for the microbiota and resident microbiomes. Large mucin proteins densely decorated with O-glycans make up the mucus lining to entrap, feed and shape the microbiota, and repress biofilm formation and virulence. How mucins exert these effects is poorly understood and critical is how the microbiota recognize, sense, and break down mucins. Here, we provide structural molecular evidence that a small mucin-binding module designated X409 recognizes clustered saccharide patches comprised of rows of inner monosaccharides in adjacent O-glycans. These patches are unique to mucins and binding to these provides an elegant mechanism to retain adherence to mucins despite trimming of O-glycans during microbial scavenging of monosaccharides from mucins. Realization of clustered saccharide patch-binding motifs provides a hitherto overlooked scenario of contextual glycan epitopes and impetus for discovery of new classes of glycan-binding proteins.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Structure, function, and implications of fucosyltransferases in health and disease

  • Ghirardello, Mattia
  • Yruela, Inmaculada
  • Merino, Pedro
  • Sackstein, Robert
  • Sanz-Martínez, Ignacio
  • Hurtado-Guerrero, Ramón
Fucosylation is a ubiquitous glycosylation event that shapes cellular communication and immunity. Catalyzed by fucosyltransferases (FUTs), this reaction encompasses diverse substrates, mechanisms, and biologic consequences. In this Review, we explore the structural and functional landscape of FUTs primarily from higher eukaryotes, with focus on the mechanistic determinants of regioselectivity, donor/acceptor coordination, and domain modularity. We highlight advances in structural biology, modeling, and enzyme engineering that clarify how FUTs decode glycan topology and specificity. Phylogenetic and structural analyses reveal two major clades of human FUTs that differ in GDP-Fuc recognition and conformational flexibility, providing a molecular rationale for their mechanistic divergence. Drawing from mammalian FUT studies, we propose a conceptual framework in which distinct family members exploit strategies including donor-induced conformational changes, exosite interactions, or local peptide cues to achieve specificity and catalytic efficiency. We also examine their roles in physiology, inflammation, immune regulation, and cancer, and summarize current FUT inhibitors and enzymebased therapeutic strategies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Mechanism of bacterial arginine n‑glycosylation: a chemically challenging post-translational modification

  • Piniello, Beatriz
  • García-García, Ana
  • Pietrucci, Fabio
  • Hurtado-Guerrero, Ramón
  • Rovira, Carme
Arginine N-glycosylation is a post-translational modification that bacterial pathogens use to subvert host immunity, yet the catalytic activation of the intrinsically weak guanidinium nucleophile has remained unresolved. Based on structural data, a direct inverting SN2 mechanism had been suggested, but alternative, more stepwise routes and the identity of the catalytic base could not be firmly established. Here, we delineate the molecular mechanism by which the nonlocus of enterocyte effacement (non-LEE)-encoded effector protein B1 (NleB1), a promising virulence factor of enteropathogens, transfers N-acetylglucosamine (GlcNAc) to arginine residues of host substrates. Using structural modeling, extensive molecular dynamics, and state-of-the-art QM/MM free-energy simulations combined with kinetic experiments, we elucidate the catalytic mechanism of NleB1. The reaction proceeds through a single-step, dissociative SN2-type mechanism, with no stable intermediate. Proton transfer to the catalytic base occurs immediately after the transition state, and is preceded by distortion (loss of planarity) of the acceptor guanidinium that primes nucleophilic attack. The simulations unambiguously identify Glu253, rather than Asp186, as the general base, and reveal that Glu253 plays multiple roles: it disrupts the planar guanidinium conformation of the acceptor arginine to enhance nucleophilicity, orients Arg117, accepts its proton, and subsequently promotes product relaxation via guanidinium replanarization, while Asp186 acts structurally to stabilize the donor substrate. Together, these residues enable a chemically demanding transformation that challenges chemical expectations for guanidinium reactivity. This study provides a comprehensive mechanistic study of arginine N-glycosylation, resolving its longstanding mechanistic conundrum and establishing catalytic rules likely conserved among Arg-specific glycosyltransferases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

FUT8 Catalysis Involves GDP-Fucose–Induced Loop Activation Promoting a Reaction at the SN1-SN2 Frontier

  • Sanz-Martínez, Ignacio
  • Tejero, Tomás
  • Hurtado-Guerrero, Ramón
  • Merino, Pedro
α1,6-Fucosyltransferase 8 (FUT8) catalyzes the core α1,6-fucosylation of N-glycans, a modification essential for the biological function of many mammalian glycoproteins. Despite its importance, the structural and mechanistic aspects of FUT8 catalysis remain incompletely understood. Here, we combine molecular dynamics, QM/MM, and metadynamics simulations to delineate the full catalytic cycle of FUT8. We reveal that GDP-fucose binding induces a concerted conformational rearrangement of two flexible loops, which cooperatively stabilize a closed, catalytically competent active site. Formation of the Michaelis complex primes the enzyme for fucose transfer via a slightly late and highly asynchronous SN2 inverting mechanism. In fact, the reaction proceeds through a late transition state in a single kinetic step (energy barrier ∼18 kcal/mol, consistent with experimental kcat values) but in three different stages, i.e.: (i) cleavage of the glycosidic bond between fucose and GDP, (ii) formation of the glycosidic bond and (iii) H-transfer from the acceptor to the catalytic Glu373, underscoring the asynchronous nature of this process. Moreover, topological calculations of the electron localization function (ELF) along the reaction coordinate reveal the transient formation of an intimate ion pair, with a lifetime of 350–800 fs, as a transient intermediate; notably, despite the cationic character of the transition state, no stable intermediate is formed. These findings highlight how structural rearrangements enable a chemically distinct catalytic process and provide a structural framework for rational inhibitor design.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Plant fucosyltransferase FUT11 distorts the sugar acceptor to catalyze via a transient oxocarbenium intermediate mechanism

  • Taleb, Víctor
  • Sanz-Martínez, Ignacio
  • Serna, Sonia
  • Bort-Griñó, María
  • Narimatsu, Yoshiki
  • Furukawa, Sanae
  • Reichardt, Niels C.
  • Clausen, Henrik
  • Merino, Pedro
  • Hurtado-Guerrero, Ramon
Glycosyltransferases catalyze glycosidic bond formation by activating the donor sugar, while the sugar acceptor substrate is considered passive, maintaining a chair conformation during catalysis. We challenge this through a multidisciplinary study of Arabidopsis thaliana FUT11, a core α1,3-fucosyltransferase essential for plant development and reproduction. AtFUT11 adopts a GT-B fold with an additional N-terminal subdomain that anchors the G0 N-glycan, while the α1,3 arm is mainly recognized by the acceptor Rossmann subdomain. The α1,6 arm remains solvent-exposed, allowing diverse modifications, while solvent exposure of the central mannose’s OH2 explains tolerance for β1,2-xylose. Remarkably, simulations suggest the catalytic base Glu158 may promote the innermost GlcNAc’s transient puckering distortion to align the hydroxyl for nucleophilic attack. This enables an asynchronous SN2-like mechanism bordering SN1 character, with formation of a transient oxocarbenium ion triggered by pyrophosphate departure, followed by nucleophilic attack coupled with proton transfer. Homology with human FUT9 explains AtFUT11’s side activity on LacNAc, revealing plasticity and evolutionary convergence between plant and mammalian antenna-fucosyltransferases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Discovery of a secreted Bacteroides fragilis mucinase that cleaves mucins with bis-T O-glycans through a carbohydrate binding module-dependent mechanism

  • Narimatsu, Yoshiki
  • Pleguezuelos-Manzano, Cayetano
  • Hornikx, Daniel
  • Goerdeler, Felix
  • Jaroentomeechai, Thapakorn
  • Flores, Katia
  • Narimatsu, Sanae
  • Boot, Charelle
  • Hansen, Lars
  • Durbesson, Fabien
  • Vincentelli, Renaud
  • Comstock, Laurie
  • Clevers, Hans
  • Taleb, Victor
  • Corzana, Francisco
  • Henrissat, Bernard
  • Clausen, Henrik
  • Hurtado-Guerrero, Ramón
  • Büll, Christian
Degradation of mucins at the host–microbial mucus interphase involves glycosidases that release monosaccharides from O-glycans and mucinases that cleave the mucin protein backbone. Mucinases recognize and cleave peptide bonds at specific sequence motifs with varying O-glycan structures required and/or permissible. Mucinases that digest mucins with intact O-glycans can potentially destroy the protective mucus, while mucinases that only digest mucins with partially degraded O-glycans may serve at a later stage of nutrient sourcing from mucins. Here, we discovered nine CBM-bearing M60-like mucinases across gut commensals and opportunists, including a conserved Bacteroides fragilis mucinase denoted HC11. We also investigated the previously described Bacteroides thetaiotaomicron mucinase BT4244, which together delineates two functional classes with distinct preferences: BT4244 for bis-Tn (GalNAcα1-O-Ser/Thr) and HC11 for bis-T (Galβ1-3GalNAcα1-O-Ser/Thr) O-glycans. Both mucinases harbor carbohydrate-binding modules (CBM32) that bind their cognate O-glycan motifs and are required – together with the catalytic domains – for efficient cleavage of extended mucin domains, which is consistent with cooperative engagement, but are not required for the cleavage of short glycopeptides. We show B. fragilis strains secrete HC11 and degrade mucins only after the removal of sialic acids. Together, these findings expand the mucinase repertoire by nine enzymes spanning commensals and opportunists, demonstrate that CBM32 domains are essential for efficient cleavage of extended mucin substrates likely by promoting multivalent engagement and substrate positioning, and nominateidentify CBM–catalytic cooperation as a mechanism and intervention point for controlling mucus turnover and barrier integrity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Sulfonylurea Bioisosteres of Sulfonic Acid in JFD 00458‐Based ST6GAL1 Inhibitors Enhance Membrane Permeability

  • Koraj, Natan
  • Dangudubiyyam, Sushmaa
  • Betances-Mora, Adelyn M.
  • Faganeli, Ema
  • Harduin-Lepers, Anne
  • Angulo, Jesús
  • Nguyen, Tan Khanh
  • Bort-Griñó, María
  • Hurtado-Guerrero, Ramon
  • Anderluh, Marko
Sialyltransferases catalyze the transfer of sialic acid to glycoconjugates within the Golgi apparatus, generating cell-surface sialoglycans that regulate cell–cell and immune communication. This process can be modulated by inhibiting α−2,6-sialyltransferase 1 (ST6GAL1), one of the most important sialyltransferases. Most β-galactoside ST6GAL1 inhibitors are polar CMP-Neu5Ac derivatives with limited membrane permeability, a limitation shared by the noncarbohydrate inhibitor JFD 00458. Here, we designed JFD 00458 analogs to improve permeability while maintaining ST6GAL1 inhibition and direct target engagement. Incorporation of sulfonic-acid bioisosteres, particularly sulfonylureas, improved passive permeability, as measured by parallel artificial membrane permeability assay, with the best analog reaching log(P_app [cm/s]) = −4.3. Potency was also improved in an expanded series of sulfonylureas, with the best inhibitor displaying an IC50 of 1.9 µM. Microscale thermophoresis confirmed direct ST6GAL1 binding, with similar apparent Kd values of approximately 22–25 µM for JFD 00458 and the optimized sulfonylureas. Saturation transfer difference NMR identified the substituted phenoxy phenyl core as a common ST6GAL1-contacting epitope, while closer contacts from the sulfonylurea-linked aromatic substituents in 6d and 6e were associated with the highest inhibitory potency across the series. These results establish sulfonylureas as membrane-permeable sulfonic-acid bioisosteres and provide a structure–activity framework for further ST6GAL1 inhibitor optimization.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Glycosyltransferases: Capturing catalytic states and conformational gating

  • Montesa, Alejandro
  • Pérez-Latorre, Alejandro
  • Merino, Pedro
  • Hurtado-Guerrero, Ramón
Glycosyltransferases (GTs) install and remodel glycans that regulate protein function and shape extracellular matrices and microbial envelopes. Recent high-resolution structures, enabled by cryo-EM and X-ray crystallography, and increasingly complemented by AI-assisted modeling, now capture GTs in mechanistically informative states, including donor–acceptor complexes, gated conformations, and membrane polymerases engaged with nascent chains. In parallel, molecular simulations, including MD and QM/MM methodologies, are being used in selected GTs to map free-energy landscapes and resolve how active-site electrostatics and conformational changes tune reaction pathways across the SN1–SN2 continuum. We highlight recent advances in protein-directed GTs that initiate glycosylation on Ser/Thr, hydroxylysine, Asn, or Arg, and in glycan remodeling GTs that modify mature N-glycans or lipid-linked oligomannose precursors. We also discuss polymerizing and lipid-acceptor GTs that couple catalysis to translocation, scaffolding, or product release. Together, these studies show how transient catalytic states, loop closure, acceptor distortion, and atypical catalytic strategies control reaction trajectory, substrate selectivity, and processivity, while exposing opportunities for inhibition.